Physician

Narinder S. Basra, M.D.

According to 2025 Medicare claims, Narinder Basra, M.D. (NPI: 1962563163) practices internal medicine in the Yuba City, CA market, with the plurality of this provider's patient population coming from Sutter, CA. Basra uses personal NPI as billing NPI and primary practice location at 95991-2962.

Basra's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 958 traditional Medicare patients, billed 70,913 HCPCS/CPT codes, and received $729,343 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 15,209 prescription claims across 781 beneficiaries totaling $1,256,999 in drug costs, led by Eliquis (Apixaban). DME data shows 1,272 claims. Open Payments data shows 2 records totaling $50. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and moved from a lower plateau to a higher plateau, from $58,324 to $133,370.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,006	74,709	$617,081
2016	979	73,486	$697,199
2017	1,115	77,026	$643,087
2018	1,139	79,244	$681,680
2019	1,111	79,618	$694,635
2020	1,042	66,695	$554,849
2021	1,035	71,050	$598,831
2022	1,029	64,150	$632,138
2023	1,004	75,468	$658,618
2024	958	70,913	$729,343

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	652	17,414	$1,107,766
2016	650	16,541	$1,097,807
2017	748	16,713	$1,136,262
2018	789	16,971	$1,198,918
2019	801	16,318	$1,186,326
2020	779	16,178	$1,171,233
2021	776	16,152	$1,233,344
2022	808	15,290	$1,259,297
2023	776	14,592	$1,470,207
2024	781	15,209	$1,256,999

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	378	1,488	$68,568
2016	344	1,373	$48,632
2017	275	1,255	$34,126
2018	250	1,219	$28,472
2019	285	1,087	$21,430
2020	242	1,052	$53,451
2021	381	1,517	$66,451
2022	379	1,410	$62,059
2023	313	1,199	$81,695
2024	300	1,272	$107,720

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	553	553	$140
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	746	1,583	$105
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	675	1,927	$75
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	722	1,990	$14
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	477	527	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	175	7,584	$146,305
Jardiance	Empagliflozin	125	6,930	$131,535
Mounjaro	Tirzepatide	48	1,654	$59,782
Januvia	Sitagliptin Phosphate	44	2,940	$50,812
Trulicity	Dulaglutide	38	1,572	$48,981

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	27	117	$56,904
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	21	$18,038
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	13	68	$4,836
E0482	Cough stimulating device, alternating positive and negative airway pressure	Y	N/R	11	$3,725
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	N/R	48	$3,286

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$50	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Narinder S. Basra, M.D.?

Tedicare shows public-source Medicare data for Narinder S. Basra, M.D. (NPI 1962563163), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Narinder S. Basra, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Narinder S. Basra, M.D.?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Narinder S. Basra, M.D. have Open Payments data?

Narinder S. Basra, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.